Related Experiment Videos

SMR-type multidrug resistance pumps

Y J Chung1, M H Saier

  • 1Department of Biology, University of California at San Diego, La Jolla, CA 92093, USA.

Current Opinion in Drug Discovery & Development
|May 31, 2001
PubMed

Insights

Multidrug resistance efflux pumps, particularly the small multidrug resistance (SMR) family, are key to antimicrobial resistance. This review details their structure and function in Bacillus subtilis, highlighting areas for future research.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Multidrug resistance (MDR) efflux pumps are critical in pathogenic microorganisms, reducing the efficacy of antimicrobial drugs.
  • These efflux pumps are phylogenetically linked to five superfamilies of transport systems.

Purpose of the Study:

  • To review the drug/metabolite transporter (DMT) superfamily, focusing on the small multidrug resistance (SMR) protein family.
  • To describe the characteristics and encoding genes of SMR efflux pumps, particularly in Bacillus subtilis.

Main Methods:

  • Phylogenetic analyses were employed to classify efflux pump superfamilies.
  • Detailed examination of SMR protein homologs within the Bacillus subtilis genome.

Main Results:

  • Identified five superfamilies of transport systems associated with MDR efflux pumps.
  • Highlighted the SMR family within the DMT superfamily, noting the presence of multiple homologs in Bacillus subtilis.
  • Discussed the potential for homo- and hetero-oligomeric pump formation, including those exporting cationic drugs.

Conclusions:

  • The SMR family plays a significant role in multidrug resistance.
  • Bacillus subtilis possesses eight SMR homologs, contributing to its resistance mechanisms.
  • Further investigation into SMR pump anomalies and unanswered questions is crucial for developing new antimicrobial strategies.

Related Concept Videos